Save time and get answers to complex questions with AI chat
Quartette side effects?What's the advised delay for milk post lipitor?How to apply for vascepa's patient assistance?The expiration date of the key patent for guselkumab?Is januvia still on the market?
See the DrugPatentWatch profile for Pazopanib
Votrient (pazopanib) received FDA approval on October 19, 2009 for the treatment of advanced renal cell carcinoma (RCC) [1].
At launch, Votrient was approved for advanced renal cell carcinoma [1].
DrugPatentWatch.com tracks drug regulatory and patent-related timelines and can be used to cross-check key dates like FDA approval [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Pazopanib :